Clinical Trial Update: Portal Vein Flow Variability to Quantify Right-Sided Hemodynamic Congestion (PORTAL) [NA]

View source ↗

Summary

The PORTAL trial investigating portal vein flow variability to quantify right-sided hemodynamic congestion in heart failure has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Snippet

Sponsor: Vrije Universiteit Brussel | Conditions: Congestion, Heart Failure | NA | Status: TERMINATED